SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-008366
Filing Date
2019-05-29
Accepted
2019-05-29 17:01:56
Documents
72
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 769991
2 form10-q_001.jpg GRAPHIC 136088
3 ex31-1.htm EX-31.1 18841
4 ex32-1.htm EX-32.1 6951
  Complete submission text file 0001493152-19-008366.txt   3490553

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE owpc-20190331.xml EX-101.INS 444243
6 XBRL SCHEMA FILE owpc-20190331.xsd EX-101.SCH 39255
7 XBRL CALCULATION FILE owpc-20190331_cal.xml EX-101.CAL 58545
8 XBRL DEFINITION FILE owpc-20190331_def.xml EX-101.DEF 136157
9 XBRL LABEL FILE owpc-20190331_lab.xml EX-101.LAB 255261
10 XBRL PRESENTATION FILE owpc-20190331_pre.xml EX-101.PRE 231241
Mailing Address 3471 WEST OQUENDO ROAD, SUITE 301 LAS VEGAS NV 89118
Business Address 3471 WEST OQUENDO ROAD, SUITE 301 LAS VEGAS NV 89118 7026050605
One World Pharma, Inc. (Filer) CIK: 0001622244 (see all company filings)

IRS No.: 611744826 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-200529 | Film No.: 19862878
SIC: 2834 Pharmaceutical Preparations